Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The coxsackievirus and adenovirus receptor pseudogene is a non-functional, duplicated genomic segment with high sequence similarity to the functional *CXADR* gene, which encodes a type I membrane receptor for group B coxsackieviruses and some adenoviruses. Pseudogenes do not code for active protein products and are not considered therapeutic targets. Multiple pseudogenes for *CXADR* exist in the human genome, including those on chromosomes 15, 18, and 21. While the functional receptor plays critical roles in viral entry, cardiac development, and cell adhesion, the pseudogene does not have biological or clinical activity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Coxsackievirus and adenovirus receptor pseudogene.